IXICO (LON:IXI) Stock Price Down 6.6% – Time to Sell?

IXICO plc (LON:IXI) was down 6.6% during mid-day trading on Friday . The stock traded as low as GBX 9.25 ($0.12) and last traded at GBX 9.25 ($0.12). Approximately 52,104 shares changed hands during trading, a decline of 23% from the average daily volume of 68,088 shares. The stock had previously closed at GBX 9.90 ($0.13).

IXICO Price Performance

The firm’s 50-day moving average is GBX 8.96 and its 200-day moving average is GBX 8.01. The company has a debt-to-equity ratio of 3.22, a current ratio of 3.64 and a quick ratio of 4.90. The company has a market capitalization of £4.47 million, a P/E ratio of -231.25, a price-to-earnings-growth ratio of -0.38 and a beta of 0.86.

Insider Activity at IXICO

In other IXICO news, insider Mark Warne bought 26,370 shares of the business’s stock in a transaction that occurred on Thursday, October 10th. The stock was bought at an average cost of GBX 9 ($0.12) per share, for a total transaction of £2,373.30 ($3,106.01). 30.28% of the stock is currently owned by company insiders.

About IXICO

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company’s technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer.